Literature DB >> 33488231

Synthesis and characterization of piperazine-substituted dihydrofuran derivatives viaMn(OAc) 3 mediated radical cyclizations.

Sait Sari1, Mehmet Yilmaz1.   

Abstract

The aim of this study is to synthesize novel piperazine-containing dihydrofuran compounds (3a-n)from radical additions and cyclizations of diacyl and alkyl-acyl piperazine derivatives (1a-h) with 1,3-dicarbonyl compounds (2a-c) mediated by Mn(OAc) 3 for the first time. From the reactions of 1a-c with dimedone (2a);1a, 1c, and 1d with acetylacetone (2b); and 1a with ethylacetoacetate(2c) ,the dihydrofuran-piperazine compounds 3a-c, 3d-f, and 3g were obtained in medium to high yields (31%-81%), respectively. In addition, dihydrofuran-piperazine compounds 3h-j and 3k-n were prepared at low to medium yields (20%-40%) from the reactions of 1e-g with 2a and 1e-h with 2c , respectively.
Copyright © 2020 The Author(s).

Entities:  

Keywords:  Mn(OAc) 3; Piperazine; dihydrofuran; radical cyclization

Year:  2020        PMID: 33488231      PMCID: PMC7751941          DOI: 10.3906/kim-2003-23

Source DB:  PubMed          Journal:  Turk J Chem        ISSN: 1300-0527            Impact factor:   1.239


  25 in total

Review 1.  Erectile dysfunction.

Authors:  T F Lue
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

2.  Manganese(III)-Based Oxidative Free-Radical Cyclizations.

Authors:  Barry B. Snider
Journal:  Chem Rev       Date:  1996-02-01       Impact factor: 60.622

3.  Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.

Authors:  Venkatesham Rachakonda; Manjula Alla; Sudha Sravanti Kotipalli; Ramesh Ummani
Journal:  Eur J Med Chem       Date:  2013-10-22       Impact factor: 6.514

4.  Design, synthesis and antimycobacterial activity of cinnamide derivatives: a molecular hybridization approach.

Authors:  Manoj D Kakwani; Prashant Suryavanshi; Muktikant Ray; M G R Rajan; Sharmila Majee; Abdul Samad; Padma Devarajan; Mariam S Degani
Journal:  Bioorg Med Chem Lett       Date:  2011-02-12       Impact factor: 2.823

5.  Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.

Authors:  Poonam Meena; Vishal Nemaysh; Manisha Khatri; Apra Manral; Pratibha Mehta Luthra; Manisha Tiwari
Journal:  Bioorg Med Chem       Date:  2015-01-13       Impact factor: 3.641

Review 6.  Targeted cancer therapies in the twenty-first century: lessons from imatinib.

Authors:  F Stegmeier; M Warmuth; W R Sellers; M Dorsch
Journal:  Clin Pharmacol Ther       Date:  2010-03-17       Impact factor: 6.875

7.  1H and 13C chemical shifts for some tetrasubstituted 2,5-diaryl di- and tetrahydrofuran derivatives.

Authors:  S Martinet; A Méou; P Brun
Journal:  Magn Reson Chem       Date:  2007-02       Impact factor: 2.447

8.  L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.

Authors:  J P Vacca; B D Dorsey; W A Schleif; R B Levin; S L McDaniel; P L Darke; J Zugay; J C Quintero; O M Blahy; E Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D₂ receptor.

Authors:  Monika Szabo; Carmen Klein Herenbrink; Arthur Christopoulos; J Robert Lane; Ben Capuano
Journal:  J Med Chem       Date:  2014-05-30       Impact factor: 7.446

10.  Synthesis of novel hybrid molecules from precursors with known antiparasitic activity.

Authors:  Haythem A Saadeh; Ibrahim M Mosleh; Mohammad S Mubarak
Journal:  Molecules       Date:  2009-04-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.